Polyrizon gets IRB approval for NASARIX allergy blocker trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. GOOG
7. INTC
8. CSX
9. IBM
10. KNX

Go back to Polyrizon gets IRB approval for NASARIX allergy blocker trial
(NASDAQ: PLRZ) Delayed: 15.31 +0.92 (6.39%)
Previous Close $14.39    52 Week High $ 
Open $14.39    52 Week Low $ 
Day High $15.31    P/E N/A 
Day Low $13.59    EPS $ 
Volume 92,925